Abiopharma

News list

Espinoza Octavio 🟢 acquired 8 shares of LIGAND PHARMACEUTICALS INC (LGND) at $95.68 Transaction Date: Dec 31, 2025 | Filing ID: 000003

Full text

News bot Jan. 7, 2026, 12:46 a.m.
🔍 Espinoza Octavio (Executive)

Company: LIGAND PHARMACEUTICALS INC (LGND)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 8
Detailed Transactions and Holdings:
- Acquired 8 shares of Common Stock at $95.676 per share (Direct)
  Date: 2025-12-31 | Code: J | equity_swap_involved: 0 | shares_owned_after: 28,575.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).